nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—CYP1A1—chronic obstructive pulmonary disease	0.198	0.509	CbGaD
Azelastine—CYP1A2—chronic obstructive pulmonary disease	0.191	0.491	CbGaD
Azelastine—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0507	0.117	CbGbCtD
Azelastine—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0507	0.117	CbGbCtD
Azelastine—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0384	0.0887	CbGbCtD
Azelastine—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0285	0.0657	CbGbCtD
Azelastine—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0226	0.052	CbGbCtD
Azelastine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.021	0.0484	CbGbCtD
Azelastine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.021	0.0484	CbGbCtD
Azelastine—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.019	0.0437	CbGbCtD
Azelastine—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0174	0.0403	CbGbCtD
Azelastine—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0174	0.0403	CbGbCtD
Azelastine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0165	0.038	CbGbCtD
Azelastine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.016	0.0368	CbGbCtD
Azelastine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.016	0.0368	CbGbCtD
Azelastine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0142	0.0328	CbGbCtD
Azelastine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0134	0.0309	CbGbCtD
Azelastine—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0132	0.0305	CbGbCtD
Azelastine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00904	0.0209	CbGbCtD
Azelastine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00881	0.0203	CbGbCtD
Azelastine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00863	0.0199	CbGbCtD
Azelastine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00769	0.0177	CbGbCtD
Azelastine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00753	0.0174	CbGbCtD
Azelastine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00711	0.0164	CbGbCtD
Azelastine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00451	0.0104	CbGbCtD
Azelastine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00426	0.00983	CbGbCtD
Azelastine—Meclizine—CYP1A2—chronic obstructive pulmonary disease	0.00061	0.315	CrCbGaD
Azelastine—Mazindol—SLC6A4—chronic obstructive pulmonary disease	0.000546	0.282	CrCbGaD
Azelastine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000275	0.00232	CcSEcCtD
Azelastine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000274	0.00231	CcSEcCtD
Azelastine—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.00229	CcSEcCtD
Azelastine—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000271	0.00228	CcSEcCtD
Azelastine—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.00227	CcSEcCtD
Azelastine—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00227	CcSEcCtD
Azelastine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000268	0.00226	CcSEcCtD
Azelastine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000268	0.00225	CcSEcCtD
Azelastine—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000267	0.00224	CcSEcCtD
Azelastine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000266	0.00224	CcSEcCtD
Azelastine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000264	0.00222	CcSEcCtD
Azelastine—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000264	0.00222	CcSEcCtD
Azelastine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000262	0.0022	CcSEcCtD
Azelastine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000258	0.00217	CcSEcCtD
Azelastine—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.000256	0.00216	CcSEcCtD
Azelastine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000256	0.00215	CcSEcCtD
Azelastine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000254	0.00214	CcSEcCtD
Azelastine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000253	0.00213	CcSEcCtD
Azelastine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000252	0.00212	CcSEcCtD
Azelastine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000252	0.00212	CcSEcCtD
Azelastine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000251	0.00212	CcSEcCtD
Azelastine—Viral infection—Prednisone—chronic obstructive pulmonary disease	0.000249	0.0021	CcSEcCtD
Azelastine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000247	0.00208	CcSEcCtD
Azelastine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000246	0.00207	CcSEcCtD
Azelastine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000246	0.00207	CcSEcCtD
Azelastine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000245	0.00206	CcSEcCtD
Azelastine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000245	0.00206	CcSEcCtD
Azelastine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000243	0.00205	CcSEcCtD
Azelastine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000243	0.00205	CcSEcCtD
Azelastine—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000242	0.00204	CcSEcCtD
Azelastine—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000242	0.00204	CcSEcCtD
Azelastine—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.000239	0.00202	CcSEcCtD
Azelastine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000239	0.00201	CcSEcCtD
Azelastine—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.000238	0.002	CcSEcCtD
Azelastine—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000232	0.00196	CcSEcCtD
Azelastine—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000232	0.00195	CcSEcCtD
Azelastine—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000232	0.00195	CcSEcCtD
Azelastine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00195	CcSEcCtD
Azelastine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00195	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000231	0.00194	CcSEcCtD
Azelastine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00023	0.00194	CcSEcCtD
Azelastine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00023	0.00194	CcSEcCtD
Azelastine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00193	CcSEcCtD
Azelastine—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00192	CcSEcCtD
Azelastine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000227	0.00191	CcSEcCtD
Azelastine—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000226	0.0019	CcSEcCtD
Azelastine—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.0019	CcSEcCtD
Azelastine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000225	0.0019	CcSEcCtD
Azelastine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00186	CcSEcCtD
Azelastine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00186	CcSEcCtD
Azelastine—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000219	0.00185	CcSEcCtD
Azelastine—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00185	CcSEcCtD
Azelastine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00184	CcSEcCtD
Azelastine—Cough—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00184	CcSEcCtD
Azelastine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.00183	CcSEcCtD
Azelastine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000217	0.00182	CcSEcCtD
Azelastine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000216	0.00182	CcSEcCtD
Azelastine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000216	0.00182	CcSEcCtD
Azelastine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000216	0.00182	CcSEcCtD
Azelastine—Cough—Montelukast—chronic obstructive pulmonary disease	0.000214	0.0018	CcSEcCtD
Azelastine—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00179	CcSEcCtD
Azelastine—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000213	0.00179	CcSEcCtD
Azelastine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000213	0.00179	CcSEcCtD
Azelastine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000213	0.00179	CcSEcCtD
Azelastine—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000213	0.00179	CcSEcCtD
Azelastine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.00179	CcSEcCtD
Azelastine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000212	0.00179	CcSEcCtD
Azelastine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00179	CcSEcCtD
Azelastine—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000212	0.00179	CcSEcCtD
Azelastine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000212	0.00179	CcSEcCtD
Azelastine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00177	CcSEcCtD
Azelastine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00177	CcSEcCtD
Azelastine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00176	CcSEcCtD
Azelastine—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000209	0.00176	CcSEcCtD
Azelastine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000208	0.00175	CcSEcCtD
Azelastine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.00175	CcSEcCtD
Azelastine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000208	0.00175	CcSEcCtD
Azelastine—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000207	0.00174	CcSEcCtD
Azelastine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.00174	CcSEcCtD
Azelastine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.00172	CcSEcCtD
Azelastine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000204	0.00172	CcSEcCtD
Azelastine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.00172	CcSEcCtD
Azelastine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000203	0.00171	CcSEcCtD
Azelastine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.00171	CcSEcCtD
Azelastine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.00169	CcSEcCtD
Azelastine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000201	0.00169	CcSEcCtD
Azelastine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00169	CcSEcCtD
Azelastine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.0002	0.00168	CcSEcCtD
Azelastine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.0002	0.00168	CcSEcCtD
Azelastine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000199	0.00168	CcSEcCtD
Azelastine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.00168	CcSEcCtD
Azelastine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00167	CcSEcCtD
Azelastine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000199	0.00167	CcSEcCtD
Azelastine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000198	0.00166	CcSEcCtD
Azelastine—Loxapine—SLC6A4—chronic obstructive pulmonary disease	0.000197	0.102	CrCbGaD
Azelastine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.00166	CcSEcCtD
Azelastine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000196	0.00165	CcSEcCtD
Azelastine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00162	CcSEcCtD
Azelastine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00161	CcSEcCtD
Azelastine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00019	0.0016	CcSEcCtD
Azelastine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00158	CcSEcCtD
Azelastine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000186	0.00157	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000186	0.00157	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.00157	CcSEcCtD
Azelastine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000184	0.00155	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000182	0.00153	CcSEcCtD
Azelastine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000182	0.00153	CcSEcCtD
Azelastine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.00153	CcSEcCtD
Azelastine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.00153	CcSEcCtD
Azelastine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000182	0.00153	CcSEcCtD
Azelastine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00018	0.00151	CcSEcCtD
Azelastine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000179	0.00151	CcSEcCtD
Azelastine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000178	0.0015	CcSEcCtD
Azelastine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000177	0.00149	CcSEcCtD
Azelastine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.00149	CcSEcCtD
Azelastine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000176	0.00148	CcSEcCtD
Azelastine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.00148	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00148	CcSEcCtD
Azelastine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00147	CcSEcCtD
Azelastine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00147	CcSEcCtD
Azelastine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00147	CcSEcCtD
Azelastine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00147	CcSEcCtD
Azelastine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000174	0.00146	CcSEcCtD
Azelastine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00146	CcSEcCtD
Azelastine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00145	CcSEcCtD
Azelastine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.00145	CcSEcCtD
Azelastine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.00144	CcSEcCtD
Azelastine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000171	0.00144	CcSEcCtD
Azelastine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000171	0.00144	CcSEcCtD
Azelastine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000169	0.00142	CcSEcCtD
Azelastine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000169	0.00142	CcSEcCtD
Azelastine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.00142	CcSEcCtD
Azelastine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00142	CcSEcCtD
Azelastine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00142	CcSEcCtD
Azelastine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000168	0.00141	CcSEcCtD
Azelastine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000167	0.00141	CcSEcCtD
Azelastine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00141	CcSEcCtD
Azelastine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00141	CcSEcCtD
Azelastine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.0014	CcSEcCtD
Azelastine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00139	CcSEcCtD
Azelastine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00139	CcSEcCtD
Azelastine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000164	0.00138	CcSEcCtD
Azelastine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00136	CcSEcCtD
Azelastine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00136	CcSEcCtD
Azelastine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00136	CcSEcCtD
Azelastine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00136	CcSEcCtD
Azelastine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000161	0.00135	CcSEcCtD
Azelastine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00016	0.00134	CcSEcCtD
Azelastine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000159	0.00134	CcSEcCtD
Azelastine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000159	0.00134	CcSEcCtD
Azelastine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00134	CcSEcCtD
Azelastine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000159	0.00133	CcSEcCtD
Azelastine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000158	0.00133	CcSEcCtD
Azelastine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000158	0.00133	CcSEcCtD
Azelastine—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00133	CcSEcCtD
Azelastine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00133	CcSEcCtD
Azelastine—Clozapine—CYP1A1—chronic obstructive pulmonary disease	0.000156	0.0806	CrCbGaD
Azelastine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00128	CcSEcCtD
Azelastine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00128	CcSEcCtD
Azelastine—Loxapine—HTR2A—chronic obstructive pulmonary disease	0.000151	0.0781	CrCbGaD
Azelastine—Clozapine—CYP1A2—chronic obstructive pulmonary disease	0.000151	0.0777	CrCbGaD
Azelastine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.00127	CcSEcCtD
Azelastine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00015	0.00127	CcSEcCtD
Azelastine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00015	0.00127	CcSEcCtD
Azelastine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.00126	CcSEcCtD
Azelastine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000147	0.00124	CcSEcCtD
Azelastine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.00123	CcSEcCtD
Azelastine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000147	0.00123	CcSEcCtD
Azelastine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000144	0.00122	CcSEcCtD
Azelastine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.00122	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00121	CcSEcCtD
Azelastine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000144	0.00121	CcSEcCtD
Azelastine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.0012	CcSEcCtD
Azelastine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000142	0.00119	CcSEcCtD
Azelastine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.00118	CcSEcCtD
Azelastine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00014	0.00118	CcSEcCtD
Azelastine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.00116	CcSEcCtD
Azelastine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000137	0.00115	CcSEcCtD
Azelastine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.00115	CcSEcCtD
Azelastine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000135	0.00114	CcSEcCtD
Azelastine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.00114	CcSEcCtD
Azelastine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000132	0.00111	CcSEcCtD
Azelastine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.00111	CcSEcCtD
Azelastine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00013	0.00109	CcSEcCtD
Azelastine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00013	0.00109	CcSEcCtD
Azelastine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00108	CcSEcCtD
Azelastine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00108	CcSEcCtD
Azelastine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00108	CcSEcCtD
Azelastine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00108	CcSEcCtD
Azelastine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00108	CcSEcCtD
Azelastine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00108	CcSEcCtD
Azelastine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00108	CcSEcCtD
Azelastine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.00107	CcSEcCtD
Azelastine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00107	CcSEcCtD
Azelastine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000127	0.00107	CcSEcCtD
Azelastine—Clozapine—HTR2A—chronic obstructive pulmonary disease	0.000127	0.0656	CrCbGaD
Azelastine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00106	CcSEcCtD
Azelastine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00106	CcSEcCtD
Azelastine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.00106	CcSEcCtD
Azelastine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000125	0.00105	CcSEcCtD
Azelastine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.00103	CcSEcCtD
Azelastine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.00103	CcSEcCtD
Azelastine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.00102	CcSEcCtD
Azelastine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.00102	CcSEcCtD
Azelastine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00102	CcSEcCtD
Azelastine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.00102	CcSEcCtD
Azelastine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000121	0.00102	CcSEcCtD
Azelastine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00102	CcSEcCtD
Azelastine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000119	0.001	CcSEcCtD
Azelastine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000985	CcSEcCtD
Azelastine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000964	CcSEcCtD
Azelastine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000959	CcSEcCtD
Azelastine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000931	CcSEcCtD
Azelastine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000908	CcSEcCtD
Azelastine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000106	0.00089	CcSEcCtD
Azelastine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000884	CcSEcCtD
Azelastine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.93e-05	0.000836	CcSEcCtD
Azelastine—Pain—Prednisolone—chronic obstructive pulmonary disease	9.46e-05	0.000796	CcSEcCtD
Azelastine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	9.28e-05	0.000781	CcSEcCtD
Azelastine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	9.14e-05	0.000769	CcSEcCtD
Azelastine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	9.11e-05	0.000767	CcSEcCtD
Azelastine—Agitation—Prednisone—chronic obstructive pulmonary disease	9.05e-05	0.000762	CcSEcCtD
Azelastine—Malaise—Prednisone—chronic obstructive pulmonary disease	8.88e-05	0.000747	CcSEcCtD
Azelastine—Vertigo—Prednisone—chronic obstructive pulmonary disease	8.85e-05	0.000745	CcSEcCtD
Azelastine—Hypertension—Prednisone—chronic obstructive pulmonary disease	8.5e-05	0.000716	CcSEcCtD
Azelastine—Myalgia—Prednisone—chronic obstructive pulmonary disease	8.38e-05	0.000706	CcSEcCtD
Azelastine—Anxiety—Prednisone—chronic obstructive pulmonary disease	8.35e-05	0.000703	CcSEcCtD
Azelastine—Discomfort—Prednisone—chronic obstructive pulmonary disease	8.28e-05	0.000697	CcSEcCtD
Azelastine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	8.15e-05	0.000686	CcSEcCtD
Azelastine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	8.04e-05	0.000676	CcSEcCtD
Azelastine—Infection—Prednisone—chronic obstructive pulmonary disease	7.98e-05	0.000672	CcSEcCtD
Azelastine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.84e-05	0.00066	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	7.32e-05	0.000616	CcSEcCtD
Azelastine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	7.31e-05	0.000616	CcSEcCtD
Azelastine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	7.22e-05	0.000607	CcSEcCtD
Azelastine—Rash—Prednisolone—chronic obstructive pulmonary disease	6.97e-05	0.000587	CcSEcCtD
Azelastine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.97e-05	0.000586	CcSEcCtD
Azelastine—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.93e-05	0.000583	CcSEcCtD
Azelastine—Headache—Prednisolone—chronic obstructive pulmonary disease	6.93e-05	0.000583	CcSEcCtD
Azelastine—Constipation—Prednisone—chronic obstructive pulmonary disease	6.87e-05	0.000578	CcSEcCtD
Azelastine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.62e-05	0.000557	CcSEcCtD
Azelastine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.57e-05	0.000553	CcSEcCtD
Azelastine—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.57e-05	0.000553	CcSEcCtD
Azelastine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	6.35e-05	0.000535	CcSEcCtD
Azelastine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	6.35e-05	0.000535	CcSEcCtD
Azelastine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.92e-05	0.000498	CcSEcCtD
Azelastine—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.77e-05	0.000485	CcSEcCtD
Azelastine—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.69e-05	0.000479	CcSEcCtD
Azelastine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.5e-05	0.000463	CcSEcCtD
Azelastine—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.31e-05	0.000447	CcSEcCtD
Azelastine—Vomiting—Prednisone—chronic obstructive pulmonary disease	5.11e-05	0.00043	CcSEcCtD
Azelastine—Rash—Prednisone—chronic obstructive pulmonary disease	5.07e-05	0.000426	CcSEcCtD
Azelastine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	5.06e-05	0.000426	CcSEcCtD
Azelastine—Headache—Prednisone—chronic obstructive pulmonary disease	5.03e-05	0.000424	CcSEcCtD
Azelastine—Nausea—Prednisone—chronic obstructive pulmonary disease	4.77e-05	0.000402	CcSEcCtD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.92e-05	0.000335	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.9e-05	0.000333	CbGpPWpGaD
Azelastine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.89e-05	0.000331	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	1.89e-05	0.00033	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.87e-05	0.000327	CbGpPWpGaD
Azelastine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.87e-05	0.000326	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.87e-05	0.000326	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.86e-05	0.000326	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.86e-05	0.000325	CbGpPWpGaD
Azelastine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.82e-05	0.000319	CbGpPWpGaD
Azelastine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.8e-05	0.000315	CbGpPWpGaD
Azelastine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.79e-05	0.000314	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.78e-05	0.000311	CbGpPWpGaD
Azelastine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.77e-05	0.000309	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.77e-05	0.000309	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.76e-05	0.000307	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.73e-05	0.000303	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.73e-05	0.000303	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.72e-05	0.000301	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.71e-05	0.000299	CbGpPWpGaD
Azelastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.65e-05	0.000289	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.63e-05	0.000285	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.62e-05	0.000284	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.61e-05	0.000282	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.59e-05	0.000278	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.58e-05	0.000276	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.56e-05	0.000273	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.56e-05	0.000273	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.55e-05	0.000271	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.55e-05	0.00027	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.51e-05	0.000264	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.47e-05	0.000258	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.47e-05	0.000257	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.46e-05	0.000256	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.45e-05	0.000254	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.45e-05	0.000254	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.44e-05	0.000252	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.44e-05	0.000251	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.44e-05	0.000251	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.43e-05	0.000249	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.42e-05	0.000249	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.41e-05	0.000247	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.4e-05	0.000245	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.39e-05	0.000243	CbGpPWpGaD
Azelastine—ADRA1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.39e-05	0.000243	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.39e-05	0.000242	CbGpPWpGaD
Azelastine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.38e-05	0.000242	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.37e-05	0.00024	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.36e-05	0.000238	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.33e-05	0.000233	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.33e-05	0.000233	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.32e-05	0.000231	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.32e-05	0.00023	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.31e-05	0.00023	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.31e-05	0.000229	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.3e-05	0.000227	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.28e-05	0.000224	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.27e-05	0.000222	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.26e-05	0.00022	CbGpPWpGaD
Azelastine—HRH1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.26e-05	0.00022	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.25e-05	0.000219	CbGpPWpGaD
Azelastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.25e-05	0.000219	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.25e-05	0.000219	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.24e-05	0.000217	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.2e-05	0.000211	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.2e-05	0.00021	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.19e-05	0.000209	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.15e-05	0.000202	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.15e-05	0.000202	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.15e-05	0.000201	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.15e-05	0.000201	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.15e-05	0.000201	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	0.0002	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.13e-05	0.000197	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.12e-05	0.000196	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.12e-05	0.000196	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.1e-05	0.000193	CbGpPWpGaD
Azelastine—HRH3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.1e-05	0.000192	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.09e-05	0.000192	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.09e-05	0.000191	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.08e-05	0.000189	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.08e-05	0.000189	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.07e-05	0.000188	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.04e-05	0.000183	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.04e-05	0.000183	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.04e-05	0.000182	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.03e-05	0.000181	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.02e-05	0.000178	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.02e-05	0.000178	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.01e-05	0.000176	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.88e-06	0.000173	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	9.86e-06	0.000172	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.6e-06	0.000168	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.56e-06	0.000167	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.51e-06	0.000166	CbGpPWpGaD
Azelastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	9.48e-06	0.000166	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.47e-06	0.000166	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.46e-06	0.000166	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	9.44e-06	0.000165	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.36e-06	0.000164	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	9.35e-06	0.000164	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.31e-06	0.000163	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	9.3e-06	0.000163	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.29e-06	0.000162	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	9.19e-06	0.000161	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.1e-06	0.000159	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.08e-06	0.000159	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.92e-06	0.000156	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.82e-06	0.000154	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.72e-06	0.000153	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	8.71e-06	0.000152	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.64e-06	0.000151	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.59e-06	0.00015	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.58e-06	0.00015	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.54e-06	0.000149	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	8.54e-06	0.000149	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.45e-06	0.000148	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.43e-06	0.000147	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.37e-06	0.000146	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	8.35e-06	0.000146	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.24e-06	0.000144	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	8.15e-06	0.000143	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.88e-06	0.000138	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.86e-06	0.000138	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.84e-06	0.000137	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.79e-06	0.000136	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.78e-06	0.000136	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.77e-06	0.000136	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.75e-06	0.000136	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.7e-06	0.000135	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	7.68e-06	0.000134	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.64e-06	0.000134	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	7.62e-06	0.000133	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	7.61e-06	0.000133	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.59e-06	0.000133	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.57e-06	0.000132	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.48e-06	0.000131	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.47e-06	0.000131	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	7.44e-06	0.00013	CbGpPWpGaD
Azelastine—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.23e-06	0.000126	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.15e-06	0.000125	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.12e-06	0.000125	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.12e-06	0.000125	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	7.1e-06	0.000124	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.1e-06	0.000124	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.08e-06	0.000124	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.07e-06	0.000124	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.06e-06	0.000123	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	7.05e-06	0.000123	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.02e-06	0.000123	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	7.01e-06	0.000123	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.97e-06	0.000122	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.96e-06	0.000122	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	6.95e-06	0.000122	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.85e-06	0.00012	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.81e-06	0.000119	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.75e-06	0.000118	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.61e-06	0.000116	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.6e-06	0.000115	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.58e-06	0.000115	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.57e-06	0.000115	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.56e-06	0.000115	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.51e-06	0.000114	CbGpPWpGaD
Azelastine—HRH3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.48e-06	0.000113	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.47e-06	0.000113	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.46e-06	0.000113	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.45e-06	0.000113	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.4e-06	0.000112	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.4e-06	0.000112	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.33e-06	0.000111	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	6.16e-06	0.000108	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.07e-06	0.000106	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.03e-06	0.000105	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.94e-06	0.000104	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.85e-06	0.000102	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.77e-06	0.000101	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.73e-06	0.0001	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.71e-06	0.0001	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.71e-06	0.0001	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	5.69e-06	9.95e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.64e-06	9.86e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.44e-06	9.51e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.39e-06	9.42e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.38e-06	9.41e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.34e-06	9.34e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.31e-06	9.29e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.27e-06	9.21e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.25e-06	9.19e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.21e-06	9.1e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.1e-06	8.92e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.08e-06	8.88e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.02e-06	8.78e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.98e-06	8.71e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.97e-06	8.69e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.95e-06	8.66e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.91e-06	8.58e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.74e-06	8.3e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.71e-06	8.24e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.69e-06	8.21e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.65e-06	8.13e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	4.59e-06	8.03e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.58e-06	8.01e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.56e-06	7.98e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.5e-06	7.87e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.5e-06	7.87e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	4.49e-06	7.86e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	4.48e-06	7.84e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.39e-06	7.68e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.3e-06	7.52e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.29e-06	7.51e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	4.29e-06	7.5e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	4.24e-06	7.41e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.22e-06	7.38e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.21e-06	7.36e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.19e-06	7.33e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.05e-06	7.09e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4e-06	7e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.97e-06	6.95e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	3.88e-06	6.79e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.81e-06	6.66e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.81e-06	6.66e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	3.72e-06	6.5e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.62e-06	6.33e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.52e-06	6.16e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.47e-06	6.07e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.47e-06	6.06e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.44e-06	6.02e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.42e-06	5.98e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	3.38e-06	5.92e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.32e-06	5.8e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.24e-06	5.66e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.24e-06	5.66e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.19e-06	5.58e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.16e-06	5.53e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.14e-06	5.49e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.09e-06	5.41e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.07e-06	5.38e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.07e-06	5.36e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.05e-06	5.34e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.02e-06	5.29e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.84e-06	4.97e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.78e-06	4.87e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.7e-06	4.73e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.58e-06	4.52e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.58e-06	4.52e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.36e-06	4.13e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.34e-06	4.09e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.14e-06	3.74e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.08e-06	3.65e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.99e-06	3.49e-05	CbGpPWpGaD
